Results 21 to 30 of about 5,155 (211)

Antivenom availability, delays and use in Australia

open access: yesToxicon: X, 2023
Antivenom is the main treatment for snake envenoming and there are ongoing concerns about availability in resource poor regions of the world. However, effective antivenom treatment for snake envenoming requires more than improved availability of safe and
Geoffrey K. Isbister
doaj   +1 more source

Antivenom for snake venom-induced neuromuscular paralysis [PDF]

open access: yes, 2017
To assess the effects of antivenom on neuromuscular paralysis in people with neurotoxic snake envenoming.
Maduwage, Kalana   +11 more
core   +3 more sources

Odds of myotoxicity following red-bellied black snake envenomation in patients that received early antivenom and late/no antivenom treatment. [PDF]

open access: yes, 2021
Odds of myotoxicity following red-bellied black snake envenomation in patients that received early antivenom and late/no antivenom treatment.
Geoffrey K. Isbister (8281572)   +2 more
core   +1 more source

Allergic reactions to antivenom in a patient bitten twice by the same snake within a month: A rare case report and literature review

open access: yesChinese Journal of Traumatology, 2017
Antivenom is the most effective method currently available for the treatment of poisonous snake bite. Allergic reactions to antivenom have been reported in the past.
Fan-Jie Zeng, Cong Chen, Ming-Hua Liu
doaj   +1 more source

Population Pharmacokinetics of an Indian F(ab')2 Snake Antivenom in Patients with Russell's Viper (Daboia russelii) Bites. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2015
There is limited information on antivenom pharmacokinetics. This study aimed to investigate the pharmacokinetics of an Indian snake antivenom in humans with Russell's viper bites.Patient data and serial blood samples were collected from patients with ...
Geoffrey K Isbister   +13 more
doaj   +1 more source

Mathematical Model of In-host Dynamics of Snakebite Envenoming

open access: yesJournal of Nigerian Society of Physical Sciences, 2022
In this paper, we develop an in-host mathematical model of snakebite envenoming that includes tissue, red blood and platelet cells of humans as specific targets of different kinds of toxins in the snake venom.
S. A. Abdullahi   +2 more
doaj   +1 more source

An Examination of the Neutralization of In Vitro Toxicity of Chinese Cobra (Naja atra) Venom by Different Antivenoms

open access: yesBiomedicines, 2020
The Chinese Cobra (Naja atra) is an elapid snake of major medical importance in southern China. We describe the in vitro neurotoxic, myotoxic, and cytotoxic effects of N.
Qing Liang   +4 more
doaj   +1 more source

Interventions for preventing reactions to snake antivenom [PDF]

open access: yesCochrane Database of Systematic Reviews, 1999
Antivenom is used to neutralise snake bite toxins in people showing evidence of envenomation. It is made from animal sera, and adverse effects, including life threatening anaphylaxis, are common.To assess the effects of drugs given routinely with snake antivenom to prevent adverse effects.Cochrane controlled trials register; contact with researchers in
I, Nuchpraryoon, P, Garner
openaire   +2 more sources

Snake Bite Management: A Scoping Review of the Literature

open access: yesPlastic and Reconstructive Surgery, Global Open, 2021
Background:. Around the world, snake bite envenomation remains an underreported human health hazard. Envenomation can cause local and systemic complications, especially when there is a lack of antivenom availability.
Jeffrey J. Russell   +2 more
doaj   +1 more source

Current treatment for venom-induced consumption coagulopathy resulting from snakebite. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2014
Venomous snakebite is considered the single most important cause of human injury from venomous animals worldwide. Coagulopathy is one of the commonest important systemic clinical syndromes and can be complicated by serious and life-threatening ...
Kalana Maduwage, Geoffrey K Isbister
doaj   +1 more source

Home - About - Disclaimer - Privacy